- NCIt
- C132146
Loading cancer entity…
Loading cancer entity…
Clinical trials
900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (101)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03892967 | Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial | completed | N/A | 50,207 | Mayo ClinicOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT06022965 | Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial | recruiting | N/A | 216 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT04631029 |
| completed |
| Phase 1 |
| 3 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Oct 3, 2025 |
| clinicaltrials |
| NCT04810052 | Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers | completed | N/A | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT07196579 | Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 | 30 | TCRx Therapeutics Co.LtdINDUSTRY | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06073951 | Evaluation of a Couple-Based Physical Activity Intervention | completed | N/A | 96 | Mayo ClinicOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT05138991 | Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors | active not recruiting | N/A | 149 | City of Hope Medical CenterOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05246670 | PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy | active not recruiting | Phase 2 | 88 | Academic and Community Cancer Research UnitedOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06063603 | Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study | completed | N/A | 51 | Mayo ClinicOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT06985355 | A Study of MHB046C Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 200 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04372641 | Testing the Safety of CB-5339 in Patients With Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06328686 | Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases | recruiting | Early Phase 1 | 10 | Emory UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07170293 | Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors | recruiting | Phase 2 | 15 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04632108 | A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 199 | Jiangsu Aosaikang Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT04889144 | PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning | completed | N/A | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04557709 | Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 4, 2025 | clinicaltrials |
| NCT07151807 | Serum IGF-1 and IGF-1Ec in Malignancy Assessment(SIGMA) | active not recruiting | — | 100 | Çanakkale Onsekiz Mart UniversityOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07124195 | Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting | not yet recruiting | Phase 3 | 126 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT00507572 | Collection of Outcomes Data for Pregnant Patients With Cancer | terminated | — | 313 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07114627 | Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients(ESCAPE) | recruiting | — | 66 | Erasmus Medical CenterOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT06231550 | A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 21 | FindCure Biosciences (ZhongShan) Co., Ltd.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07110363 | A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer | not yet recruiting | Phase 1 | 58 | Biotroy TherapeuticsINDUSTRY | 0 | Aug 7, 2025 | clinicaltrials |
| NCT03579446 | Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | terminated | Early Phase 1 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07092748 | A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors | recruiting | Phase 1 | 110 | Zhejiang Hisun Pharmaceutical Co. Ltd.INDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT01309490 | Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients | terminated | Phase 1 / Phase 2 | 5 | Jewish General HospitalOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06710158 | Study of SC-102 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 120 | Tianjin ConjuStar Biologics Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07088588 | Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors | not yet recruiting | Phase 1 | 105 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT05506982 | Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain | completed | Phase 1 | 11 | Emory UniversityOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT07077252 | Phase I/II Study of SCTB39G in Advanced Solid Tumours | not yet recruiting | Phase 1 / Phase 2 | 30 | Sinocelltech Ltd.INDUSTRY | 1 | Jul 22, 2025 | clinicaltrials |
| NCT02376127 | Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion | completed | — | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06666270 | Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT01286896 | Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors | completed | Phase 1 | 43 | The Netherlands Cancer InstituteOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07050641 | Phase I/II Study of SCTB39-1 in Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 110 | Sinocelltech Ltd.INDUSTRY | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07051161 | Impact of Interventional Endoscopy on Quality of Life in Patients With Acute Respiratory Distress Due to Tumor Compression or Obstruction of the Lower Respiratory Tract(ENDoRA) | not yet recruiting | — | 60 | University Hospital, GrenobleOTHER | 0 | Jul 4, 2025 | clinicaltrials |
| NCT01628640 | Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors | completed | Phase 1 | 17 | Mayo ClinicOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT05383703 | Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor(MNC-168) | completed | Phase 1 | 12 | Moon (Guangzhou) Biotechnology Co., Ltd.INDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07045454 | A Study of MHB118C Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 200 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Jul 1, 2025 | clinicaltrials |
| NCT04530487 | Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT06630247 | A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors | terminated | Phase 1 | 9 | ExelixisINDUSTRY | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04754529 | Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors | completed | N/A | 27 | Roswell Park Cancer InstituteOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT07030478 | A Study to Evaluate the Safety and Tolerability of EP0089 | not yet recruiting | Phase 1 / Phase 2 | 190 | Ellipses PharmaINDUSTRY | 0 | Jun 22, 2025 | clinicaltrials |
| NCT07002502 | Immune Modulation With PRaG-1 Treatment | not yet recruiting | Phase 2 | 19 | Second Affiliated Hospital of Soochow UniversityOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT02419495 | Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies | terminated | Phase 1 | 221 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06494046 | Defining Musical Toxicity and Its Effect on Patient Well-being | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06999538 | Real-life Performance Evaluation of the LiFlow X-ray Platform(LiFE) | not yet recruiting | — | 400 | University Hospital, AngersOTHER_GOV | 0 | May 31, 2025 | clinicaltrials |
| NCT04820894 | Perception of Cure Among Patients With Metastatic Cancer | withdrawn | — | 0 | City of Hope Medical CenterOTHER | 0 | May 23, 2025 | clinicaltrials |
| NCT05118802 | Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis | completed | — | 46 | Thomas Jefferson UniversityOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT04555837 | Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer | completed | Phase 1 / Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT03080883 | Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy | completed | Phase 3 | 370 | Academic and Community Cancer Research UnitedOTHER | 1 | May 18, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Oct 7, 2025source: clinicaltrials